4 Reviews
If you are from China, you’ll get a job even if you’re completely unqualified. Free lunch.
Low compensation. No remote work unless you’re Chinese. Untalented coworkers. Terrible management. Office is old. Products are bad copies of Tesla.
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced the publication of Phase 3 clinical data in the Jo
Seres Therapeutics, Inc. (NASDAQ:MCRB - Get Rating) saw a large growth in short interest in September. As of September 30th, there was short interest totalling 4,930,000 shares, a growth of 45.9% from the September 15th total of 3,380,000 shares. Based on an average daily volume of 1,050,000 shares…